| --- | --- | |-----------------------------------------------------------------------------|-------| | | | | ENGINEERING MEDICINES | | | TO IMPROVE PATIENT CARE *VIRIDIAN VRDN-001 & VRDN-002 initial clinical data | | | August 15, 2022 | | Cautionary note regarding forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of words such as, but not limited to, "anti ...